Gramicidin from Bacillus aneurinolyticus (Bacillus brevis)
Product #:
S1205
Image
SKU-Pack Size
Stock
Price($)
Quantity
-
-
S1205-100MG
In-stock
45
-
+
S1205-500MG
In-stock
131
-
+
S1205-1G
In-stock
229
-
+
S1205-5G
In-stock
902
-
+
Details
l General Information |
Product Name | Gramicidin from Bacillus aneurinolyticus (Bacillus brevis) |
General description | Linear polypeptide antibiotic complex. |
Synonym | Gramicidine; Gramicidinum |
Purity | Linear polypeptide antibiotic complex. A mixture of gramicidins A, B, C, and D. | CAS Number | 1405-97-6 |
Formula | C99H140N20O17 | Molecular Weight | 1882.332 |
Suitability | BioReagent,
suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | White to Off white Powder or crystalline powder |
l Biological Information |
Biochem/Physiol
Actions | Linear polypeptide antibiotic mixture of gramicidin A, B, C, and D. Gramicidin A acts as neutral carrier and helps in the establishment of ion flux across the lipid b.Gramicidin D, a channel-forming ionophore that flip-flops slowly across the membrane is a known Pgp substrate and surprisingly was found to inhibit Pgp ATPase activity. This inhibition was reversed by other Pgp substrates suggesting a common drug binding site among MDR substrate-type drugs and chemosensitizers. |
Application | Gramicidin from Bacillus aneurinolyticus (Bacillus brevis) has been used as a control to measure the rate of diffusion of protonated β-lactams through the lipid b in liposome swelling assay. It has also been used as an analyte for the purpose of infrared laser desorption or ionization from silicon. |
l Storage |
Storage temp. | 2-8°C |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |